D3net: Driving drug design with deep multimodal and multi-task learning

In this project, UCB Biopharma and the Institute for Machine Learning team up to investigate the use Deep Learning-based AI methods in various stages of drug design. This projects aims at advancing the technology further to increase the efficiency of drug design, decrease toxic effect, and develop novel Deep Learning methods for molecules.